The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | |||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | ||||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | FIGI | (to the nearest dollar) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
ACELYRIN INC | COM | 00445A100 | 10,450,000 | 500,000 | SH | SOLE | NONE | 500,000 | 0 | 0 | ||
ACLARIS THERAPEUTICS INC | COM | 00461U105 | 30,085,382 | 2,901,194 | SH | SOLE | NONE | 2,901,194 | 0 | 0 | ||
ADAPTIVE BIOTECHNOLOGIES COR | COM | 00650F109 | 4,351,106 | 648,451 | SH | SOLE | NONE | 648,451 | 0 | 0 | ||
AGENUS INC | COM NEW | 00847G705 | 7,516,688 | 4,697,930 | SH | SOLE | NONE | 4,697,930 | 0 | 0 | ||
ALECTOR INC | COM | 014442107 | 24,829,203 | 4,131,315 | SH | SOLE | NONE | 4,131,315 | 0 | 0 | ||
ALIGN TECHNOLOGY INC | COM | 016255101 | 79,225,969 | 224,030 | SH | SOLE | NONE | 224,030 | 0 | 0 | ||
ALPHATEC HLDGS INC | COM NEW | 02081G201 | 457,249 | 25,431 | SH | SOLE | NONE | 25,431 | 0 | 0 | ||
ALPHATEC HLDGS INC | NOTE 0.750% 8/0 | 02081GAB8 | 82,406,723 | 70,750,000 | PRN | SOLE | NONE | 70,750,000 | 0 | 0 | ||
ALX ONCOLOGY HLDGS INC | COM | 00166B105 | 9,386,749 | 1,249,900 | SH | SOLE | NONE | 1,249,900 | 0 | 0 | ||
AMYRIS INC | NOTE 1.500%11/1 | 03236MAJ0 | 26,191,500 | 137,850,000 | PRN | SOLE | NONE | 137,850,000 | 0 | 0 | ||
ANAPTYSBIO INC | COM | 032724106 | 23,480,964 | 1,154,423 | SH | SOLE | NONE | 1,154,423 | 0 | 0 | ||
ASCENDIS PHARMA A/S | NOTE 2.250% 4/0 | 04351PAD3 | 113,150,000 | 124,000,000 | PRN | SOLE | NONE | 124,000,000 | 0 | 0 | ||
AXONICS INC | COM | 05465P101 | 28,959,232 | 573,791 | SH | SOLE | NONE | 573,791 | 0 | 0 | ||
BIOCRYST PHARMACEUTICALS INC | COM | 09058V103 | 19,654,835 | 2,791,880 | SH | SOLE | NONE | 2,791,880 | 0 | 0 | ||
BIOGEN INC | COM | 09062X103 | 34,735,179 | 121,942 | SH | SOLE | NONE | 121,942 | 0 | 0 | ||
BOSTON SCIENTIFIC CORP | COM | 101137107 | 38,785,235 | 717,050 | SH | SOLE | NONE | 717,050 | 0 | 0 | ||
BRIDGEBIO PHARMA INC | NOTE 2.250% 2/0 | 10806XAD4 | 38,552,328 | 62,294,000 | PRN | SOLE | NONE | 62,294,000 | 0 | 0 | ||
BRIDGEBIO PHARMA INC | NOTE 2.500% 3/1 | 10806XAB8 | 101,094,132 | 128,338,000 | PRN | SOLE | NONE | 128,338,000 | 0 | 0 | ||
COMPASS THERAPEUTICS INC | COM | 20454B104 | 18,934,588 | 5,954,273 | SH | SOLE | NONE | 5,954,273 | 0 | 0 | ||
CRINETICS PHARMACEUTICALS IN | COM | 22663K107 | 11,718,622 | 650,312 | SH | SOLE | NONE | 650,312 | 0 | 0 | ||
CULLINAN ONCOLOGY INC | COM | 230031106 | 20,539,387 | 1,908,865 | SH | SOLE | NONE | 1,908,865 | 0 | 0 | ||
CUTERA INC | NOTE 2.250% 6/0 | 232109AD0 | 7,202,906 | 11,500,000 | PRN | SOLE | NONE | 11,500,000 | 0 | 0 | ||
DANAHER CORPORATION | COM | 235851102 | 13,296,000 | 55,400 | SH | SOLE | NONE | 55,400 | 0 | 0 | ||
DAY ONE BIOPHARMACEUTICALS I | COM | 23954D109 | 40,140,047 | 3,361,813 | SH | SOLE | NONE | 3,361,813 | 0 | 0 | ||
DBV TECHNOLOGIES S A | SPONSORED ADR | 23306J101 | 23,004,792 | 12,107,785 | SH | SOLE | NONE | 12,107,785 | 0 | 0 | ||
DECIPHERA PHARMACEUTICALS IN | COM | 24344T101 | 51,341,580 | 3,646,419 | SH | SOLE | NONE | 3,646,419 | 0 | 0 | ||
DICE THERAPEUTICS INC | COM | 23345J104 | 47,849,200 | 1,029,901 | SH | SOLE | NONE | 1,029,901 | 0 | 0 | ||
DYNE THERAPEUTICS INC | COM | 26818M108 | 15,501,060 | 1,377,872 | SH | SOLE | NONE | 1,377,872 | 0 | 0 | ||
ENANTA PHARMACEUTICALS INC | COM | 29251M106 | 22,219,834 | 1,038,310 | SH | SOLE | NONE | 1,038,310 | 0 | 0 | ||
ESPERION THERAPEUTICS INC NE | COM | 29664W105 | 1,245,369 | 895,949 | SH | SOLE | NONE | 895,949 | 0 | 0 | ||
EXACT SCIENCES CORP | NOTE 0.375% 3/0 | 30063PAC9 | 134,691,036 | 131,000,000 | PRN | SOLE | NONE | 131,000,000 | 0 | 0 | ||
GLAUKOS CORP | COM | 377322102 | 74,371,154 | 1,044,392 | SH | SOLE | NONE | 1,044,392 | 0 | 0 | ||
GUARDANT HEALTH INC | NOTE 11/1 | 40131MAB5 | 193,131,609 | 268,252,000 | PRN | SOLE | NONE | 268,252,000 | 0 | 0 | ||
GUARDANT HEALTH INC | COM | 40131M109 | 9,666,000 | 270,000 | SH | SOLE | NONE | 270,000 | 0 | 0 | ||
HARROW HEALTH INC | COM | 415858109 | 27,656,324 | 1,452,538 | SH | SOLE | NONE | 1,452,538 | 0 | 0 | ||
HILLEVAX INC | COM | 43157M102 | 21,474,539 | 1,249,246 | SH | SOLE | NONE | 1,249,246 | 0 | 0 | ||
ILLUMINA INC | NOTE 8/1 | 452327AK5 | 22,599,467 | 22,645,000 | PRN | SOLE | NONE | 22,645,000 | 0 | 0 | ||
IMMUNOCORE HLDGS PLC | ADS | 45258D105 | 28,062,899 | 468,027 | SH | SOLE | NONE | 468,027 | 0 | 0 | ||
INSMED INC | NOTE 0.750% 6/0 | 457669AB5 | 2,953,125 | 3,500,000 | PRN | SOLE | NONE | 3,500,000 | 0 | 0 | ||
INSMED INC | NOTE 1.750% 1/1 | 457669AA7 | 38,004,813 | 39,963,000 | PRN | SOLE | NONE | 39,963,000 | 0 | 0 | ||
INTEGRA LIFESCIENCES HLDGS C | NOTE 0.500% 8/1 | 457985AM1 | 13,311,000 | 14,500,000 | PRN | SOLE | NONE | 14,500,000 | 0 | 0 | ||
INTUITIVE SURGICAL INC | COM NEW | 46120E602 | 42,339,011 | 123,820 | SH | SOLE | NONE | 123,820 | 0 | 0 | ||
INVITAE CORP | NOTE 2.000% 9/0 | 46185LAB9 | 14,968,713 | 16,781,000 | PRN | SOLE | NONE | 16,781,000 | 0 | 0 | ||
IONIS PHARMACEUTICALS INC | NOTE 4/0 | 462222AD2 | 50,004,113 | 52,740,000 | PRN | SOLE | NONE | 52,740,000 | 0 | 0 | ||
IRHYTHM TECHNOLOGIES INC | COM | 450056106 | 49,923,066 | 478,557 | SH | SOLE | NONE | 478,557 | 0 | 0 | ||
KARYOPHARM THERAPEUTICS INC | NOTE 3.000%10/1 | 48576UAA4 | 43,016,352 | 65,976,000 | PRN | SOLE | NONE | 65,976,000 | 0 | 0 | ||
KEROS THERAPEUTICS INC | COM | 492327101 | 45,960,496 | 1,143,865 | SH | SOLE | NONE | 1,143,865 | 0 | 0 | ||
KRYSTAL BIOTECH INC | COM | 501147102 | 12,691,879 | 108,108 | SH | SOLE | NONE | 108,108 | 0 | 0 | ||
KRYSTAL BIOTECH INC | COM | 501147102 | 15,648,363 | 133,291 | SH | SOLE | NONE | 133,291 | 0 | 0 | ||
LEGEND BIOTECH CORP | SPONSORED ADS | 52490G102 | 38,401,458 | 556,301 | SH | SOLE | NONE | 556,301 | 0 | 0 | ||
MARAVAI LIFESCIENCES HLDGS I | COM CL A | 56600D107 | 22,432,421 | 1,804,700 | SH | SOLE | NONE | 1,804,700 | 0 | 0 | ||
MERUS N V | COM | N5749R100 | 40,631,455 | 1,543,162 | SH | SOLE | NONE | 1,543,162 | 0 | 0 | ||
MINERALYS THERAPEUTICS INC | COM | 603170101 | 9,382,615 | 550,300 | SH | SOLE | NONE | 550,300 | 0 | 0 | ||
MIRATI THERAPEUTICS INC | COM | 60468T105 | 8,693,781 | 240,625 | SH | SOLE | NONE | 240,625 | 0 | 0 | ||
NANOSTRING TECHNOLOGIES INC | NOTE 2.625% 3/0 | 63009RAD1 | 115,400,772 | 145,520,000 | PRN | SOLE | NONE | 145,520,000 | 0 | 0 | ||
NATERA INC | COM | 632307104 | 56,097,730 | 1,152,851 | SH | SOLE | NONE | 1,152,851 | 0 | 0 | ||
NEOGENOMICS INC | NOTE 1.250% 5/0 | 64049MAA8 | 26,302,500 | 28,000,000 | PRN | SOLE | NONE | 28,000,000 | 0 | 0 | ||
NEOGENOMICS INC | NOTE 0.250% 1/1 | 64049MAB6 | 36,082,568 | 48,678,000 | PRN | SOLE | NONE | 48,678,000 | 0 | 0 | ||
NEUROCRINE BIOSCIENCES INC | COM | 64125C109 | 88,016,037 | 933,362 | SH | SOLE | NONE | 933,362 | 0 | 0 | ||
NEVRO CORP | NOTE 2.750% 4/0 | 64157FAC7 | 100,947,924 | 109,251,000 | PRN | SOLE | NONE | 109,251,000 | 0 | 0 | ||
NEVRO CORP | COM | 64157F103 | 45,155,275 | 1,776,368 | SH | SOLE | NONE | 1,776,368 | 0 | 0 | ||
NOVOCURE LTD | NOTE 11/0 | 67011XAB9 | 118,179,303 | 135,834,000 | PRN | SOLE | NONE | 135,834,000 | 0 | 0 | ||
NUVASIVE INC | NOTE 0.375% 3/1 | 670704AJ4 | 50,067,315 | 55,323,000 | PRN | SOLE | NONE | 55,323,000 | 0 | 0 | ||
NUVATION BIO INC | COM CL A | 67080N101 | 7,421,220 | 4,122,900 | SH | SOLE | NONE | 4,122,900 | 0 | 0 | ||
ORTHOPEDIATRICS CORP | COM | 68752L100 | 33,378,971 | 761,208 | SH | SOLE | NONE | 761,208 | 0 | 0 | ||
OUTSET MED INC | COM | 690145107 | 31,938,248 | 1,460,368 | SH | SOLE | NONE | 1,460,368 | 0 | 0 | ||
PARAGON 28 INC | COM | 69913P105 | 37,894,804 | 2,136,122 | SH | SOLE | NONE | 2,136,122 | 0 | 0 | ||
PENUMBRA INC | COM | 70975L107 | 22,654,287 | 65,844 | SH | SOLE | NONE | 65,844 | 0 | 0 | ||
PULMONX CORP | COM | 745848101 | 13,101,636 | 999,362 | SH | SOLE | NONE | 999,362 | 0 | 0 | ||
RAPT THERAPEUTICS INC | COM | 75382E109 | 18,408,280 | 984,400 | SH | SOLE | NONE | 984,400 | 0 | 0 | ||
REPLIGEN CORP | COM | 759916109 | 13,014,320 | 92,000 | SH | SOLE | NONE | 92,000 | 0 | 0 | ||
REPLIMUNE GROUP INC | COM | 76029N106 | 11,320,214 | 487,520 | SH | SOLE | NONE | 487,520 | 0 | 0 | ||
RHYTHM PHARMACEUTICALS INC | COM | 76243J105 | 13,902,505 | 843,087 | SH | SOLE | NONE | 843,087 | 0 | 0 | ||
SEAGEN INC | COM | 81181C104 | 8,178,973 | 42,497 | SH | SOLE | NONE | 42,497 | 0 | 0 | ||
TERNS PHARMACEUTICALS INC | COM | 880881107 | 16,120,580 | 1,842,352 | SH | SOLE | NONE | 1,842,352 | 0 | 0 | ||
THERMO FISHER SCIENTIFIC INC | COM | 883556102 | 14,243,775 | 27,300 | SH | SOLE | NONE | 27,300 | 0 | 0 | ||
TRAVERE THERAPEUTICS INC | NOTE 2.250% 3/0 | 89422GAA5 | 22,804,031 | 28,350,000 | PRN | SOLE | NONE | 28,350,000 | 0 | 0 | ||
TRAVERE THERAPEUTICS INC | NOTE 2.500% 9/1 | 761299AB2 | 50,500,740 | 56,031,000 | PRN | SOLE | NONE | 56,031,000 | 0 | 0 | ||
VAXCYTE INC | COM | 92243G108 | 86,014,309 | 1,722,353 | SH | SOLE | NONE | 1,722,353 | 0 | 0 | ||
VIR BIOTECHNOLOGY INC | COM | 92764N102 | 17,871,307 | 728,549 | SH | SOLE | NONE | 728,549 | 0 | 0 | ||
VIRIDIAN THERAPEUTICS INC | COM | 92790C104 | 28,697,877 | 1,206,300 | SH | SOLE | NONE | 1,206,300 | 0 | 0 | ||
XENON PHARMACEUTICALS INC | COM | 98420N105 | 70,391,591 | 1,828,353 | SH | SOLE | NONE | 1,828,353 | 0 | 0 |